Trends in the crossover of patients in phase III oncology clinical trials in the USA

BACKGROUND: The incorporation of crossover in randomised controlled trials is accepted as an ethical obligation, especially in cancer clinical trials. The more common type of crossover is crossover allowance, which allows patients assigned to one arm to switch to another arm if there is an establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Justin, Gupta, Shruti, Patel, Sunny J, Kota, Vamsi, Guddati, Achuta K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738270/
https://www.ncbi.nlm.nih.gov/pubmed/33343701
http://dx.doi.org/10.3332/ecancer.2020.1142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738270/
https://www.ncbi.nlm.nih.gov/pubmed/33343701
http://dx.doi.org/10.3332/ecancer.2020.1142

Ejemplares similares